Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

30.10.2017

1 Ann Surg
1 Ann Surg Oncol
2 Anticancer Res
4 Br J Cancer
2 Cancer Res
1 Clin Cancer Res
3 Gastrointest Endosc
1 Gut
1 Int J Cancer
6 PLoS One



    Ann Surg

  1. RAHBARI NN, Carr PR, Jansen L, Chang-Claude J, et al
    Time of Metastasis and Outcome in Colorectal Cancer.
    Ann Surg. 2017 Oct 23. doi: 10.1097/SLA.0000000000002564.
    >> Share


    Ann Surg Oncol

  2. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    >> Share


    Anticancer Res

  3. KAJITANI T, Makiyama A, Arita S, Shimokawa H, et al
    Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:6459-6468.
    >> Share

  4. MERCIER J, Voutsadakis IA
    A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:5925-5934.
    >> Share


    Br J Cancer

  5. THERKILDSEN C, Ladelund S, Smith-Hansen L, Lindberg LJ, et al
    Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    >> Share

  6. HOU L, Zhu D, Liang Y, Tian X, et al
    Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    >> Share

  7. RUZZO A, Graziano F, Galli F, Galli F, et al
    Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
    Br J Cancer. 2017;117:1269-1277.
    >> Share

  8. MURAKAMI T, Kikuchi H, Ishimatsu H, Iino I, et al
    Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
    Br J Cancer. 2017;117:1360-1370.
    >> Share


    Cancer Res

  9. LULLA AR, Slifker MJ, Zhou Y, Lev A, et al
    miR-6883 family miRNAs target CDK4/6 to induce G1 phase cell cycle arrest in colon cancer cells.
    Cancer Res. 2017 Oct 23. pii: canres.1767.2017.
    >> Share

  10. KIM SY, Jung JH, Lee HJ, Soh H, et al
    [18F]fluorothymidine positron emission tomography informs the synergistic efficacy of capecitabine and trifluridine/tipiracil in colon cancer.
    Cancer Res. 2017 Oct 20. pii: canres.1406.2017.
    >> Share


    Clin Cancer Res

  11. LAL N, White BS, Goussous G, Pickles OJ, et al
    KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer.
    Clin Cancer Res. 2017 Oct 23. pii: clincanres.1090.2017.
    >> Share


    Gastrointest Endosc

  12. SUMIMOTO K, Tanaka S, Shigita K, Hirano D, et al
    Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team.
    Gastrointest Endosc. 2017;85:816-821.
    >> Share

  13. AL-BAWARDY B, Rajan E, Wong Kee Song LM
    Over-the-scope clip-assisted endoscopic full-thickness resection of epithelial and subepithelial GI lesions.
    Gastrointest Endosc. 2017;85:1087-1092.
    >> Share

  14. IMPERIALE TF
    The rising prevalence of early-onset colorectal cancer: Ready and FIT to tackle?
    Gastrointest Endosc. 2017;86:900-902.
    >> Share


    Gut

  15. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    >> Share


    Int J Cancer

  16. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    >> Share


    PLoS One

  17. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    >> Share

  18. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    >> Share

  19. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    >> Share

  20. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    >> Share

  21. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    >> Share

  22. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016